Ifosfamide in thymic neoplasms

Oncology

Volumn 65, Issue SUPPL. 2, 2003, Pages 44-45

  Daniele, O ^a   Fornasiero, A ^a  

^a Ospedale Immacolata Concezione   (Italy)

Author keywords

Chemotherapy; Ifosfamide; Thymoma

Indexed keywords

ALKYLATING AGENT; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG ACTIVITY; DRUG EFFECT; DRUG TOLERABILITY; HUMAN; PRIORITY JOURNAL; RECURRENT CANCER; THYMOMA;

ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS; HUMANS; IFOSFAMIDE; THYMOMA; THYMUS NEOPLASMS; TREATMENT OUTCOME;

EID: 0242383229     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073357     Document Type: Conference Paper

References (18)

1. Thomas CR Jr, Wright CD, Loehrer PJ: Thymoma: State of the art. J Clin Oncol 1999;17:2280.
2. Maggi G, Casadio C, Cavallo A: Thymoma: Results of 241 operated cases. Ann Thorac Surg 1991;51:152.
3. Rea F, Sartori F, Loy M: Chemotherapy and operation for invasive thymoma. J Cardiovasc Surg 1993;106:543.
4. Hu E, Levine J: Chemotherapy of malignant thymoma. Case report and review of the literature. Cancer 1986;1101-1104.
5. Kirkove C, Berghmans J, Noel H: Dramatic response of recurrent invasive thymoma to high doses of corticosteroids. Clin Oncol 1992;4:64-66.
6. Bonomi PD, Finklestein D, Aisner S: Phase II trial of cisplatin in metastatic or recurrent thymoma. Am J Clin Oncol 1993;16:342-345.
7. Boston B: Chemotherapy of invasive thymoma. Cancer 1976;38:59-62.
8. Wilkins EW Jr, Edmunds LH Jr, Castleman B: Cases of thymoma at the Massachusetts General Hospital. J Thorac Cardiovasc Surg 1966;15:1224-1260.
9. Loehrer PJ, Kim KM, Aisner SC: Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: Final results of an intergroup trial. J Clin Oncol 1997;15:3093-3099.
10. Fornasiero A, Daniele O, Ghiotto C: Chemotherapy for invasive thymoma: A 13-year experience. Cancer 1991;68:30-33.
11. Giaccone G, Ardissoni A, Kirkpatrick A: Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer. Lung Cancer Cooperative Group. J Clin Oncol 1996;1:814-820.
12. Koizumi T, Takabayashi Y, Yamagishi S: Chemotherapy for advanced thymic carcinoma. Am J Clin Oncol 2002;25:266-268.
13. Dabrowska W: Results of chemotherapy in patients with thymoma according to the records at the Institute of Oncology in Warsaw in the years 1958-1973. Nowotwory 1975;25:107-113.
14. Harper P, Highly M, Ronkin E: The treatment of malignant thymoma with single-agent ifosfamide. Br J Cancer 1991;63(suppl 13):7.
15. Highley MS, Underhill CR, Parnis FX: Treatment of invasive thymoma with single-agent ifosfamide. J Clin Oncol 1999;17:2737-2744.
16. Goldel N, Boning L, Fredrik A: Chemotherapy of invasive thymoma: A retrospective study of 22 cases. Cancer 1989;63:1493-1500.
17. Fornasiero A, Daniele O, Ghiotto C: Chemotherapy for invasive thymoma. J Clin Oncol 1990;8:1419-1423.
18. Loehrer PJ, Jiroutek M, Aisner S: Combined etoposide, ifosfamide and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma. An intergroup trial. Cancer 2001;91:2010-2015.